The antibacterial activity of fatty acids (FA) is well known in the literature and represents a
promising option for develo** the next-generation of antibacterial agents to treat a broad …

Resistance to therapeutic antimicrobial agents is recognized as a growing problem for both
human and veterinary medicine, and the need to address the issue in both of these linked …

Despite efforts to develop new antibiotics, antibacterial resistance still develops too fast for
drug discovery to keep pace. Often, resistance against a new drug develops even before it …

Antimicrobial resistance (AMR) is a global problem hindering treatment of bacterial
infections, rendering many aspects of modern medicine less effective. AMR genes (ARGs) …

Mobile genetic elements (MGEs) are one of the main vectors for the spread of antimicrobial
resistance (AMR) across bacteria, due to their ability to move horizontally between bacterial …

Pathogenic antibiotic resistant bacteria pose one of the most important health challenges of
the 21st century. The overuse and abuse of antibiotics coupled with the natural evolutionary …

There is urgent need for new therapeutic strategies to fight the global threat of antibiotic
resistance. The focus of this Perspective is on chemical agents that target the most common …

Antimicrobial resistance is one of the biggest threats to global health as current antibiotics
are becoming useless against resistant infectious pathogens. Consequently, new …

The global spread of antibiotic resistance has posed a serious threat to public healthcare
and undermined decades of progress made in the fight against bacterial infections. It has …

Antibiotic resistance, especially in gram‐negative bacteria, is spreading globally and rapidly.
Development of new antibiotics lags behind; therefore, novel approaches to the problem of …